Delivery Order SPE2DX22D0060-SPE2D826F01D6
- Not listed
- This delivery order, awarded on October 5, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order has a ceiling value of $1,036.80 and is structured as a firm fixed price contract with no set-aside designation, indicating competitive award authority. The contract is funded through the Medical Supply Chain, a...
- This delivery order, awarded October 15, 2025, represents a $124,080.64 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was made through competitive procurement with no...
- This delivery order, awarded on September 10, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,218.87 with a firm fixed price structure, was competitively awarded without a set-aside designation to support the Medical Supply Chain, a defense-focused federal agency. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- This delivery order, awarded on October 13, 2025, represents a $17,720.43 firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery. The contract, which is a child award under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical designated SPE2DX, was issued without a set-aside designation and has an ultimate completion date of October 14, 2025. Performance will be...
- This delivery order, awarded on October 16, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order is valued at $874,612.30 on a firm fixed-price basis with an ultimate completion date of October 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was competitively awarded this contract...
- This delivery order, awarded on October 6, 2025, represents a child contract under AmerisourceBergen Drug Corp's $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and running through December 2026. The contract, valued at $1,288.50 with firm fixed pricing, calls for pharmaceutical and medical supply delivery to support federal medical procurement needs. The award was made competitively with no set-aside designation to...
- This delivery order, awarded on October 16, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order carries a ceiling value of $1,317.56 and involves firm fixed pricing with no set-aside designation, indicating competitive award through open competition. The contract is funded by the...
- This delivery order, awarded September 1, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The specific delivery order carries a ceiling value of $6,139.94 with firm fixed pricing and an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- This delivery order, awarded to AmerisourceBergen Drug Corp on October 8, 2025, represents a $10,173.33 firm fixed-price contract funded by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded without set-aside designation and will be performed at...
- This delivery order, awarded September 1, 2025, represents a child contract under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $255,145.60 firm fixed price delivery order is funded through the Medical Supply Chain, a defense agency component, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competitively...
- SPE2DX22D0060Indefinite Delivery Contract
- SPE2DX22D0060-SPE2D826F01D6Delivery Order
This delivery order, awarded on October 16, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The $15,967.84 firm fixed-price delivery order was competitively awarded with no set-aside designation to supply pharmaceutical products and medical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through this comprehensive global pharmaceutical support vehicle. The award is funded by the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical and medical commodities to support defense healthcare operations. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive capability in delivering a wide range of pharmaceutical products including brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The completion date is scheduled for October 17, 2025, with performance taking place at the company's corporate office location in Conshohocken, PA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 10/16/25 |